Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients
Russell, James A, Vincent, Jean-Louis, Kjalbye, Anne Louise, Olsson, HAaAaAeANk, Blemings, Allan, Spapen, Herbert, Carl, Peder, Laterre, Pierre-Francois, Grundemar, Lars
Published in Critical care (London, England) (15.08.2017)
Published in Critical care (London, England) (15.08.2017)
Get full text
Journal Article